Jusu, S.M.; Obayemi, J.D.; Salifu, A.A.; Nwazojie, C.C.; Uzonwanne, V.O.; Odusanya, O.S.; Soboyejo, W.O.
PLGA-CS-PEG Microparticles for Controlled Drug Delivery in the Treatment of Triple Negative Breast Cancer Cells. Appl. Sci. 2021, 11, 7112.
https://doi.org/10.3390/app11157112
AMA Style
Jusu SM, Obayemi JD, Salifu AA, Nwazojie CC, Uzonwanne VO, Odusanya OS, Soboyejo WO.
PLGA-CS-PEG Microparticles for Controlled Drug Delivery in the Treatment of Triple Negative Breast Cancer Cells. Applied Sciences. 2021; 11(15):7112.
https://doi.org/10.3390/app11157112
Chicago/Turabian Style
Jusu, Sandra Musu, John David Obayemi, Ali Azeko Salifu, Chukwudalu Clare Nwazojie, Vanessa Obiageli Uzonwanne, Olushola Segun Odusanya, and Winnston Oluwole Soboyejo.
2021. "PLGA-CS-PEG Microparticles for Controlled Drug Delivery in the Treatment of Triple Negative Breast Cancer Cells" Applied Sciences 11, no. 15: 7112.
https://doi.org/10.3390/app11157112
APA Style
Jusu, S. M., Obayemi, J. D., Salifu, A. A., Nwazojie, C. C., Uzonwanne, V. O., Odusanya, O. S., & Soboyejo, W. O.
(2021). PLGA-CS-PEG Microparticles for Controlled Drug Delivery in the Treatment of Triple Negative Breast Cancer Cells. Applied Sciences, 11(15), 7112.
https://doi.org/10.3390/app11157112